Cancer patients who relied on Moffitt Cancer Center through Humana Medicare Advantage plans lost in-network access to one of the country’s leading treatment facilities when the contract between the two organizations ended on July 1. The split forces affected enrollees into a difficult choice: find a new insurance plan during a narrow enrollment window or absorb the full cost of out-of-network care at Moffitt. No public statements from either Moffitt or Humana have detailed how many patients are affected, what drove the contract breakdown, or what transition support is available.
Why Moffitt’s exit from Humana’s network creates urgent pressure
The contract termination between Moffitt Cancer Center and Humana did not arrive with a long public runway. For patients mid-treatment or scheduled for follow-up care, the July 1 cutoff date turned a billing relationship into a personal crisis. Cancer care depends on continuity. Switching oncologists, transferring records, and restarting treatment protocols at a new facility can delay care at moments when timing matters most.
Federal rules offer one safety valve. Beneficiaries may qualify for a Special Enrollment Period when notified of a significant change in a plan’s provider network, according to the Centers for Medicare and Medicaid Services. That window allows enrollees to move to a different Medicare Advantage plan or switch to Original Medicare without waiting for the annual open enrollment season. The same federal guidance also states that beneficiaries may qualify for a Special Enrollment Period if they joined a plan based on misleading or incorrect information.
The catch is that eligibility for this enrollment window hinges on notification. Patients who received a formal written notice from Humana about the network change have a clear path to trigger the Special Enrollment Period. Those who learned about it secondhand, whether from a doctor’s office, a news report, or word of mouth, face a murkier process. The gap between those two groups could determine who keeps uninterrupted access to specialized cancer care and who falls through the cracks.
Federal enrollment rules and what the record shows
The strongest documented protection for affected patients sits in federal enrollment policy maintained by CMS. The Special Enrollment Period provision was designed for exactly this kind of disruption: a plan’s provider network changes after a beneficiary has already enrolled, and the change removes access to a provider the enrollee was counting on. The provision does not require the patient to prove fault or negotiate with the insurer. It simply requires that the network change qualifies as significant and that the beneficiary was notified.
What the public record does not show is equally telling. Neither Moffitt nor Humana has released data on the number of Medicare Advantage enrollees affected by the split. No official statements have explained whether the contract ended over reimbursement rates, administrative disagreements, or other factors. And no disclosure has confirmed how many patients received the kind of direct, written notification from Humana that would clearly establish their eligibility for a Special Enrollment Period. Without that information, patients are left to piece together their options from general federal guidance rather than specific instructions tailored to this situation.
Unanswered questions and what patients should do first
Several gaps in the public record leave affected enrollees without a full picture. The most pressing is the notification question. If Humana sent notices only to some enrollees, or if letters arrived after the July 1 cutoff, patients could find themselves technically eligible for a Special Enrollment Period but practically unsure how to invoke it. It is also unclear whether Humana is offering any temporary continuity-of-care arrangements that would let patients finish active treatment cycles at Moffitt at in-network rates, or whether all such accommodations are being handled case by case and out of public view.
In this information vacuum, patients are left to take the first steps themselves. The starting point is confirming whether a Special Enrollment Period applies in their situation. That typically means locating any written communication from Humana about Moffitt leaving the network, including mailed letters, secure online messages, or plan emails. If a notice exists, patients can point to it when contacting Medicare or a new plan. If it does not, they may still be able to argue that they relied on the prior network when choosing their coverage, but the process is likely to be more complicated.
Beneficiaries can also review general coverage and plan comparison tools on federal sites such as HealthCare.gov, which explain how private plans interact with federal programs and outline options for changing coverage. While these resources do not address the Moffitt–Humana split specifically, they provide baseline rules about when and how people can switch plans, what counts as a qualifying life event, and how to avoid gaps in coverage during a transition.
For now, the lack of detailed public guidance from either Moffitt or Humana means that each affected patient must navigate a highly technical process with limited, general information. The central unresolved questions – who was notified, what temporary protections exist, and how many people are caught in the middle – will determine whether the end of this contract is a bureaucratic inconvenience or a barrier to timely cancer care. Until those answers are made public, the clearest roadmap remains the federal enrollment rules laid out by Medicare and enforced through federal regulators, leaving patients to advocate for themselves within a system that was not designed for sudden, high-stakes provider losses.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
